Emerging Markets Earnings Roundup: Johnson & Johnson, Abbott (Part 1)
This article was originally published in PharmAsia News
Executive Summary
Emerging markets received a lot of attention during the fourth quarter earnings calls of both Abbott Laboratories and J&J. CEOs at both companies proved upbeat on the year ahead and talked about momentum across product lines from medical devices to pharmaceuticals.
You may also be interested in...
J&J’s Consumer Woes Finally Subside As Pharma Continues Strong
The multinational health care company reported significant growth in 2013 that largely was driven by its pharmaceutical division, but bolstered by the resurrection of its long-plagued consumer brands.
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia 2014: Distribution, Manufacturing To The Fore
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.